Ellume’s COVID-19 home test recall most serious, FDA says
(Reuters) – The U.S. Food and Drug Administration classified the recall of Ellume’s over-the-counter COVID-19 home test as Class 1, (More…)

Important Takeaways:
The Japanese government warns of an 80% chance of a magnitude 9 Nankai Trough earthquake in 30 years, (More...)(Reuters) – The U.S. Food and Drug Administration classified the recall of Ellume’s over-the-counter COVID-19 home test as Class 1, (More…)
By Gus Trompiz and Giancarlo Navach
PARIS/MILAN (Reuters) – Italian pasta makers are fearful of a substantial supply squeeze in (More…)
MADRID (Reuters) – New cascades of red-hot lava tumbled into the Atlantic Ocean off Spain’s La Palma on Wednesday morning, (More…)
By Alan Charlish and Felix Hoske
NAREWKA, Poland (Reuters) – Hundreds of migrants huddled around forest campfires in freezing temperatures (More…)
By Manas Mishra
(Reuters) – The U.S. government will buy another $1 billion worth of the COVID-19 pill made by (More…)
By Lawrence Hurley
WASHINGTON (Reuters) – The U.S. Supreme Court on Tuesday tackled the question of whether a decision by (More…)
By Nate Raymond
(Reuters) – The Oklahoma Supreme Court on Tuesday overturned a $465 million judgment against Johnson & Johnson (More…)
By Jonnelle Marte
(Reuters) – U.S. consumers are spending more and ramping up credit card balances, reversing a shift during (More…)
By Kristina Cooke, Mica Rosenberg and Caitlin O’Hara
NOGALES, Mexico (Reuters) – Leo fled his hometown in southern Mexico after (More…)
By Lizbeth Diaz and Jose Luis Gonzalez
TIJUANA/CIUDAD JUAREZ, Mexico (Reuters) -There were fewer crossings at the Mexico-United States border (More…)